NewsAbout UsContact UsWebsiteCipla Foundation SABizcommunity
News
Is your probiotic gluten-free?As more information about the benefits of probiotic use is becoming increasingly available, Professor Leon Dicks, head of the probiotic and antimicrobial peptide laboratory in the Department of Microbiology at Stellenbosch University, stresses the importance of choosing a probiotic that is gluten-free. 16 Oct 2017 Read more>>

Team up against breast cancerAmongst cancers affecting females, breast cancer still reduces life expectancy when diagnosed. However, if diagnosed early, it is treatable and survival rates are very good. 13 Oct 2017 Read more>>

Inflammatory bowel disease should not be a career-enderInflammatory bowel disease (IBD) affects individuals in their most productive years, but its symptoms should not deter individuals from continuing to practise their chosen professions. This according to Sister Karin Davidson, IBD Nurse at the Vincent Pallotti Hospital, speaking at the recent Congress of the South African Gastroenterology Society and Association of Surgeons of South Africa. 28 Sep 2017 Read more>>

Positive news for MS sufferers with hopes of becoming parentsMultiple sclerosis (MS) sufferers should not be discouraged from having families, as the view on the prospect of women with MS, carrying pregnancies to term, is shifting. 18 Sep 2017 Read more>>

More than half of health-conscious people suffer from digestive health problemsMore than half (54%) of health-conscious South Africans experience digestive health problems, according to the 2017 Cipla Digestive Health Survey conducted among 400 health-conscious individuals. Respondents indicated that 77% suffer from bloating, 76% said they have constipation and 28% experience regular diarrhoea. 15 Sep 2017 Read more>>

Celebrating a great man's legacyOn 18 July 2017 South Africans from all walks of life celebrated Mandela Day. 25 Jul 2017 Read more>>

Cipla collaborates with American Cancer Society to increase access to cancer treatment in AfricaCipla Ltd, the global pharmaceutical company and owner of Cipla Medpro, South Africa's third-largest pharmaceutical manufacturer, announced a groundbreaking market access agreement with the American Cancer Society (ACS), the Clinton Health Access Imitative (CHAI) and the pharmaceutical company, Pfizer, to expand access to 16 essential cancer treatment medications, including chemotherapies, into Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania. 7 Jul 2017 Read more>>

The link between gut bacteria and children developing allergiesThe probability that a child will develop an allergy is being proven to be largely related to their microbiome - the bugs that live on us and in us. Research from the University of California, San Francisco shows that if an infant's beneficial microbes, more commonly understood as ‘gut flora', are disturbed in the first few weeks of their life, they have a higher chance of developing allergies and asthma. 2 May 2017 Read more>>

How probiotics can alleviate the symptoms of IBSInternational Irritable Bowel Syndrome Awareness Month 3 Apr 2017 Read more>>

Medical disaster relief unit assists Hout Bay fire victimsWith a recent fire destroying 2,200 homes and leaving about 10,000 people displaced in Mandela Park Hout Bay, the community was left traumatised and in desperate need of support. The Cipla Foundation installed a disaster relief medical unit, which is now fully operational and located on the Hout Bay sports grounds in close proximity to the affected area to provide assistance to the community. 24 Mar 2017 Read more>>

Medical disaster relief unit deployed to Hout Bay to assist fire victimsAn estimated 15,000 people were left homeless after the fire that ravaged Mandela Park Hout Bay left the community traumatised and in desperate need of support. The Cipla Foundation will be deploying a disaster relief medical unit to provide assistance to the affected community. 20 Mar 2017 Read more>>

#ImpactMoments: Shap'Left Medstores - Eastern CapeVery often within the NGO space the good work that many NGOs do isn't communicated very well and the story of the people on the ground that have been impacted, how the individuals lives have changed for the better and then as a direct result how their community has benefitted. 15 Mar 2017 Read more>>

The importance of deworming kids - School Health WeekThe 4th to the 8th of March 2017 is School Health Week, which presents an excellent reminder for parents about the importance of deworming their children. According to the World Health Organisation, more than 600 million school-age children worldwide are at risk of parasitic worm infections and an estimated 400 million of these children remain untreated. 1 Mar 2017 Read more>>

Cipla bursary scheme now open for entries Cipla SA, South Africa's third largest pharmaceutical company, is encouraging all students in their first, second or third/final year, who want to make a difference in the world by becoming a part of the pharmaceutical industry, to apply for a bursary at the company. 14 Feb 2017 Read more>>

Cipla launches revolutionary respiratory inhaler in SACipla today announced the launch of its innovative inhaler called Synchrobreathe. This state-of-the-art breath-actuated inhaler (BAI) will bring great relief to millions of South Africans with obstructive airway diseases (OAD) such as asthma. 18 Jan 2017 Read more>>

David Grier to run 1,100km in 20 days to bring 10 smiles to 10 children - The Power of 10 challengeCipla Foundation, Cipla SA's social enterprise division, is planning an adventure which will see endurance athletes David Grier and Andrew Stuart running 1,100 kilometres over a period of 20 days with the aim of raising R110,000 over this period for the Cipla Miles for Smiles initiative, which raises funds and awareness for Operation Smile. 14 Nov 2016 Read more>>

#NotAskingForAnything | Cipla Foundation SAOur #NotAskingForAnything campaign is more than just a social media hashtag. It's a heartfelt invitation for anyone - from regular, good-hearted people, all the way to big businesses and corporations - to join us in doing whatever we can for real people in need. 7 Nov 2016 Read more>>

The Evolution of Asthma TreatmentAsthma continues to be a significant problem globally, as the Global Asthma Report lists the disease as the 14th most important disorder in the world in terms of the extent and duration of disability. While current treatment programmes are effective for patients with mild-to-moderate asthma, patients who fail to control their disease can escalate to acute asthma or even become unresponsive to current treatment efforts, placing them at an increased risk of passing away from the disease. 30 Sep 2016 Read more>>

The global and South African need for ECD centresA proper foundation is the key to emotional, physical and cognitive success in childhood, as well as later on in life. Investing in Early Childhood Development (ECD) will set children up for these sorts of achievements. The question is, to what extent has the world and, more specifically, South Africa invested in ECD? 13 Sep 2016 Read more>>

Early childhood development campus launched in Kaboweni- MbombelaThe Department of Social Development in Mbombela, in collaboration with the Cipla Foundation, on 2 June launched a specialised early childhood development (ECD) campus in the informal settlement of Kaboweni. This fire resistant structure is geared to provide quality ECD facilities and services to the 40,000 inhabitants of the settlement. 12 Sep 2016 Read more>>

Cipla Announces Africa Expansion Strategy During International AIDS ConferenceOn the 18th July 2016, Cipla Limited today announced that negotiations to establish manufacturing facilities in Morocco and later in Algeria are in advanced stages of discussion. The pharmaceutical aims to establish these facilities through joint ventures, thereby increasing its antiretroviral (ARV) manufacturing capacity in Africa. 18 Jul 2016 Read more>>

Cipla completes acquisition of generic businesses in USCipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla (EU) Limited has closed the transaction to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The acquisition was made by Cipla (EU) Limited through a wholly owned special purpose vehicle which would merge into InvaGen Pharmaceuticals Inc. after the acquisition. The combined revenue for the two companies for the year-ended 2015 is over USD230 million. 4 May 2016 Read more>>

Dr Hamied on AsthmaPatent monopolies on life-saving drugs: the biggest killer of our time? It's a burning issue: should pharmaceutical companies be granted patent monopolies on life-saving drugs they have developed if it is costing millions of lives? 13 Feb 2016 Read more>>

Biz Press Office